| Oct 17 |
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories
|
| Oct 17 |
AbbVie wins FDA nod for advanced Parkinson's therapy
|
| Oct 17 |
After rejections, AbbVie secures approval for Parkinson’s drug
|
| Oct 17 |
U.S. FDA Approves VYALEV™ (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease
|
| Oct 16 |
Allergan Aesthetics to Present New Data at 2024 American Society for Dermatologic Surgery (ASDS) to Showcase Depth Across Facial Aesthetics and Insight into Patient Perception
|
| Oct 14 |
Dividend Investor Who 'Doubled' His Passive Income to $1,000 a Month in Six Months Reveals Portfolio: Top 8 High-Yield Stocks
|
| Oct 14 |
Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces
|
| Oct 14 |
2 Magnificent Dividend Stocks to Buy and Hold Forever
|
| Oct 14 |
Prediction: These 2 High-Yield Dividend Stocks Will Outperform the S&P 500 Index in the Coming Decade
|
| Oct 12 |
There Are Only 28 S&P 500 Companies Warren Buffett Can't Buy Outright. Here's the Best of the Bunch for Income Investors.
|
